Görkem Karamustafao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Görkem Karamustafao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Fatma Kulali
Department of Radiology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkiye
2 shared publications - Servet Emir
Department of Internal Medicine, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
2 shared publications - Sevde Nur Emir
University of Health Sciences, Umraniye Training and Research Hospital, Department of Radiology, Istanbul, Turkey
2 shared publications Cengiz Sabanoglu
University of Health Sciences – Ümraniye Training and Research Hospital
1 shared publication- Gülbanu Güner
Health Sciences University, Umraniye Training and Research Hospital, Department of Radiology, Istanbul, Turkey
1 shared publication - Hüseyin Aykut
Department of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
1 shared publication
Latest Publications
- 25 August 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (10) , 822-830
CT-derived composite coronary wall thickness as a marker of early vessel wall remodeling in patients with CAD-RADS 0–2
Background: Early coronary atherosclerosis may involve vessel wall remodeling before significant luminal stenosis develops. Coronary computed tomography angiography (CCTA) may enable assessment of vessel wall geometry using composite measurements derived from luminal and outer vessel boundaries. Purpose: To evaluate composite coronary wall thickness (TWT) using a CCTA-based virtual intravascular ultrasound (IVUS) approach in patients with CAD-RADS 0–2 and to assess its associations with cardiovascular risk factors, coronary calcium burden, positive remodeling, and CAD-RADS category. Material and Methods: This retrospective single-center study included 234 patients (129 men, 105 women; mean age = 57 ± 11 years) who underwent clinically indicated CCTA between January 2023 and September 2025 and were classified as CAD-RADS 0–2. TWT was measured using a virtual IVUS-based reconstruction in proximal and mid segments of the left main, left anterior descending, left circumflex, and right coronary arteries. Associations between TWT and clinical or imaging variables were evaluated using multivariable regression and segment-level mixed-effects models. Results: TWT was significantly higher in proximal than mid coronary segments ( P < 0.001). Hypertension, LDL cholesterol, and positive remodeling were independently associated with increased TWT ( P < 0.05), whereas diabetes mellitus was not. TWT independently predicted higher CAD-RADS category (odds ratio = 2.41; P = 0.003) and showed good discriminative performance (area under the curve = 0.81). Moderate correlations were observed between TWT and coronary calcium burden (r = 0.40–0.60; P < 0.001). Conclusion: CCTA-derived TWT is associated with CAD-RADS category, cardiovascular risk factors, and coronary calcium burden, reflecting early vessel wall remodeling preceding overt luminal disease.
- 25 August 2026
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (10) , 822-830
CT-derived composite coronary wall thickness as a marker of early vessel wall remodeling in patients with CAD-RADS 0–2
Background: Early coronary atherosclerosis may involve vessel wall remodeling before significant luminal stenosis develops. Coronary computed tomography angiography (CCTA) may enable assessment of vessel wall geometry using composite measurements derived from luminal and outer vessel boundaries. Purpose: To evaluate composite coronary wall thickness (TWT) using a CCTA-based virtual intravascular ultrasound (IVUS) approach in patients with CAD-RADS 0–2 and to assess its associations with cardiovascular risk factors, coronary calcium burden, positive remodeling, and CAD-RADS category. Material and Methods: This retrospective single-center study included 234 patients (129 men, 105 women; mean age = 57 ± 11 years) who underwent clinically indicated CCTA between January 2023 and September 2025 and were classified as CAD-RADS 0–2. TWT was measured using a virtual IVUS-based reconstruction in proximal and mid segments of the left main, left anterior descending, left circumflex, and right coronary arteries. Associations between TWT and clinical or imaging variables were evaluated using multivariable regression and segment-level mixed-effects models. Results: TWT was significantly higher in proximal than mid coronary segments ( P < 0.001). Hypertension, LDL cholesterol, and positive remodeling were independently associated with increased TWT ( P < 0.05), whereas diabetes mellitus was not. TWT independently predicted higher CAD-RADS category (odds ratio = 2.41; P = 0.003) and showed good discriminative performance (area under the curve = 0.81). Moderate correlations were observed between TWT and coronary calcium burden (r = 0.40–0.60; P < 0.001). Conclusion: CCTA-derived TWT is associated with CAD-RADS category, cardiovascular risk factors, and coronary calcium burden, reflecting early vessel wall remodeling preceding overt luminal disease.
- 25 November 2025
- Published by Springer Nature in Emergency Radiology
- Vol. 33 (1) , 61-71
Can contrast-enhanced CT assist in the early assessment of biliary obstruction? A quantitative attenuation-based study
Purpose To evaluate the diagnostic utility of bile duct attenuation measured on contrast-enhanced computed tomography (CT) in differentiating choledocholithiasis, malignant biliary obstruction, benign biliary obstruction, and cholangitis. Methods This retrospective study included 208 patients who underwent contrast-enhanced abdominal CT followed by endoscopic retrograde cholangiopancreatography (ERCP) within three days. Intraductal bile attenuation was measured using two region of interest (ROI) techniques (elliptical and 4-point), with all measurements obtained strictly from bile-filled ductal segments. Secondary morphologic features were also assessed. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis, and multivariate logistic regression identified independent predictors of malignancy. Results Mean attenuation values were significantly higher in malignant obstruction and choledocholithiasis than in benign biliary obstruction and cholangitis (p < 0.001). For malignant obstruction, the 4-point method yielded 96% sensitivity and 81% specificity at a cut-off of ≥ 29 HU (AUC: 0.97), while the elliptical method yielded 100% sensitivity and 80% specificity at ≥ 60 HU (AUC: 0.95). Elliptical ROI attenuation and bile duct wall thickness were independent predictors of malignancy (p = 0.010 and p < 0.001, respectively). Interobserver agreement was excellent for both techniques (ICC > 0.89). Conclusion When measured strictly within bile-filled ductal segments, CT-based attenuation provides useful quantitative information for differentiating common causes of biliary obstruction. Combined with ductal wall thickness and secondary morphologic features, attenuation analysis may enhance the diagnostic value of routine contrast-enhanced CT, particularly in settings where advanced imaging modalities are limited or delayed. Graphical Abstract
- 25 November 2025
- Published by Springer Nature in Emergency Radiology
- Vol. 33 (1) , 61-71
Can contrast-enhanced CT assist in the early assessment of biliary obstruction? A quantitative attenuation-based study
Purpose To evaluate the diagnostic utility of bile duct attenuation measured on contrast-enhanced computed tomography (CT) in differentiating choledocholithiasis, malignant biliary obstruction, benign biliary obstruction, and cholangitis. Methods This retrospective study included 208 patients who underwent contrast-enhanced abdominal CT followed by endoscopic retrograde cholangiopancreatography (ERCP) within three days. Intraductal bile attenuation was measured using two region of interest (ROI) techniques (elliptical and 4-point), with all measurements obtained strictly from bile-filled ductal segments. Secondary morphologic features were also assessed. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis, and multivariate logistic regression identified independent predictors of malignancy. Results Mean attenuation values were significantly higher in malignant obstruction and choledocholithiasis than in benign biliary obstruction and cholangitis (p < 0.001). For malignant obstruction, the 4-point method yielded 96% sensitivity and 81% specificity at a cut-off of ≥ 29 HU (AUC: 0.97), while the elliptical method yielded 100% sensitivity and 80% specificity at ≥ 60 HU (AUC: 0.95). Elliptical ROI attenuation and bile duct wall thickness were independent predictors of malignancy (p = 0.010 and p < 0.001, respectively). Interobserver agreement was excellent for both techniques (ICC > 0.89). Conclusion When measured strictly within bile-filled ductal segments, CT-based attenuation provides useful quantitative information for differentiating common causes of biliary obstruction. Combined with ductal wall thickness and secondary morphologic features, attenuation analysis may enhance the diagnostic value of routine contrast-enhanced CT, particularly in settings where advanced imaging modalities are limited or delayed. Graphical Abstract
- Open Access
- 24 November 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 133
Can abbreviated MRI replace standard protocols in IPMN surveillance? A retrospective comparative study
With the advancements in imaging technologies and the widespread use of magnetic resonance imaging (MRI), the detection rates of pancreatic cystic lesions (PCLs) have significantly increased. While most of these lesions are benign, branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) pose a potential risk for malignant transformation, necessitating regular clinical and radiological follow-up. However, conventional MRI protocols are time-consuming and resource-intensive, prompting the need for shorter, cost-effective alternatives without compromising diagnostic accuracy. This study aims to evaluate the diagnostic performance and clinical feasibility of abbreviated MRI (A-MRI) protocols for BD-IPMN surveillance compared to standard MRI (S-MRI). This was a single-center, retrospective study including patients with BD-IPMN who underwent follow-up MRI between January 2022 and December 2024. Three MRI protocols were analyzed: (1) S-MRI, comprising T2-weighted imaging, dynamic contrast-enhanced (DCE) T1-weighted imaging, 3D MR cholangiopancreatography (MRCP), and diffusion-weighted imaging (DWI); (2) A-MRI protocol 1 (A-MRI-1), including MRCP and T2-weighted sequences; and (3) A-MRI protocol 2 (A-MRI-2), incorporating MRCP, T2-weighted, and DWI sequences. The images were evaluated for lesion size progression (≥ 5 mm in 2 years), mural nodules, cyst wall thickening, main pancreatic duct dilation, and parenchymal atrophy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for A-MRI protocols in detecting degeneration signs. A total of 124 patients (mean age: 64 years, 55.6% female) and 124 lesions were analyzed. The detection rates of key degeneration markers were similar between S-MRI and A-MRI protocols, except for contrast-enhanced mural nodules, which were not identifiable with A-MRI due to the lack of DCE sequences. The overall sensitivity, specificity, PPV, and NPV for A-MRI in detecting BD-IPMN degeneration markers were 100%, 98.3%, 71.4%, and 100%, respectively. A-MRI protocols demonstrated a comparable diagnostic performance to S-MRI while significantly reducing scan time (from ~ 40–50 min to 7–12 min). However, false-positive mural nodule detection was higher with A-MRI, potentially leading to unnecessary follow-up imaging. The addition of DWI in A-MRI-2 did not provide a significant diagnostic advantage over A-MRI-1. A-MRI is a viable alternative for BD-IPMN follow-up, offering substantial reductions in imaging duration and costs while maintaining high diagnostic accuracy. However, the absence of DCE sequences may lead to false-positive mural nodule detection, necessitating further evaluation in selected cases.
- 24 November 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 133
Open AccessCan abbreviated MRI replace standard protocols in IPMN surveillance? A retrospective comparative study
With the advancements in imaging technologies and the widespread use of magnetic resonance imaging (MRI), the detection rates of pancreatic cystic lesions (PCLs) have significantly increased. While most of these lesions are benign, branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) pose a potential risk for malignant transformation, necessitating regular clinical and radiological follow-up. However, conventional MRI protocols are time-consuming and resource-intensive, prompting the need for shorter, cost-effective alternatives without compromising diagnostic accuracy. This study aims to evaluate the diagnostic performance and clinical feasibility of abbreviated MRI (A-MRI) protocols for BD-IPMN surveillance compared to standard MRI (S-MRI). This was a single-center, retrospective study including patients with BD-IPMN who underwent follow-up MRI between January 2022 and December 2024. Three MRI protocols were analyzed: (1) S-MRI, comprising T2-weighted imaging, dynamic contrast-enhanced (DCE) T1-weighted imaging, 3D MR cholangiopancreatography (MRCP), and diffusion-weighted imaging (DWI); (2) A-MRI protocol 1 (A-MRI-1), including MRCP and T2-weighted sequences; and (3) A-MRI protocol 2 (A-MRI-2), incorporating MRCP, T2-weighted, and DWI sequences. The images were evaluated for lesion size progression (≥ 5 mm in 2 years), mural nodules, cyst wall thickening, main pancreatic duct dilation, and parenchymal atrophy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for A-MRI protocols in detecting degeneration signs. A total of 124 patients (mean age: 64 years, 55.6% female) and 124 lesions were analyzed. The detection rates of key degeneration markers were similar between S-MRI and A-MRI protocols, except for contrast-enhanced mural nodules, which were not identifiable with A-MRI due to the lack of DCE sequences. The overall sensitivity, specificity, PPV, and NPV for A-MRI in detecting BD-IPMN degeneration markers were 100%, 98.3%, 71.4%, and 100%, respectively. A-MRI protocols demonstrated a comparable diagnostic performance to S-MRI while significantly reducing scan time (from ~ 40–50 min to 7–12 min). However, false-positive mural nodule detection was higher with A-MRI, potentially leading to unnecessary follow-up imaging. The addition of DWI in A-MRI-2 did not provide a significant diagnostic advantage over A-MRI-1. A-MRI is a viable alternative for BD-IPMN follow-up, offering substantial reductions in imaging duration and costs while maintaining high diagnostic accuracy. However, the absence of DCE sequences may lead to false-positive mural nodule detection, necessitating further evaluation in selected cases.